Azienda Sanitaria Locale 3, Torino
Quick facts
Phase 3 pipeline
- Colchicine (for 1 month) · Immunology / Rheumatology / Cardiovascular
Colchicine inhibits microtubule polymerization by binding to tubulin, thereby suppressing inflammatory cell migration and reducing production of inflammatory mediators. - Colchicine (for 3 months) · Rheumatology / Immunology
Colchicine inhibits microtubule polymerization by binding to tubulin, thereby suppressing inflammatory cell migration and reducing production of inflammatory mediators. - Colchicine (for 6 months) · Immunology / Cardiovascular / Rheumatology
Colchicine inhibits microtubule polymerization by binding to tubulin, thereby suppressing inflammatory cell migration and reducing production of inflammatory mediators.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Azienda Sanitaria Locale 3, Torino portfolio CI brief
- Azienda Sanitaria Locale 3, Torino pipeline updates RSS
Frequently asked questions about Azienda Sanitaria Locale 3, Torino
What is Azienda Sanitaria Locale 3, Torino's pipeline?
Azienda Sanitaria Locale 3, Torino has 3 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Colchicine (for 1 month), Colchicine (for 3 months), Colchicine (for 6 months).
Related
- Sector hub: All tracked pharma companies